This role is critical to shaping the company's portfolio through high-impact partnerships and transactions in the late-stage therapeutic area.
Base: $308,000 - $377,000; Bonus/Equity: Incentive compensation and equity included; Benefits: Not specified
Must-have
Nice-to-have
Not specified